for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Moderna Inc

MRNA.OQ

Latest Trade

220.14USD

Change

0.00(-0.00%)

Volume

1,628,450

Today's Range

213.50

 - 

221.49

52 Week Range

54.23

 - 

227.57

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Moderna Plans To Expand Production To Make COVID-19 Vaccine Boosters, Supply More Countries- WSJ

June 21 (Reuters) - :MODERNA PLANS TO EXPAND PRODUCTION TO MAKE COVID-19 VACCINE BOOSTERS, SUPPLY MORE COUNTRIES- WSJ.Further company coverage: MRNA.O. ((Reuters.Briefs@thomsonreuters.com;)).

U.S. CDC Says Meeting To Evaluate The Evidence And Assess The Risk Of Myocarditis Has Been Rescheduled

June 17 (Reuters) - :CDC SAYS ITS MEETING TO FURTHER EVALUATE THE EVIDENCE AND ASSESS THE RISK OF MYOCARDITIS FOLLOWING MRNA VACCINATION FOR COVID-19 HAS BEEN RESCHEDULED.U.S. CDC SAYS JUNE 18 COVID-19 MEETING IS RESCHEDULED DUE TO JUNETEENTH NATIONAL HOLIDAY; DISCUSSION TO BE RESCHEDULED ON JUNE 23-25 ACIP MEETING. ((reuters.briefs@thomsonreuters.com;)).

Moderna Submits Authorization Application For Its COVID-19 Vaccine In Adolescents In Switzerland

June 14 (Reuters) - Moderna Inc <MRNA.O>::MODERNA INC - MODERNA SUBMITS AUTHORIZATION APPLICATION FOR ITS COVID-19 VACCINE IN ADOLESCENTS IN SWITZERLAND.MODERNA INC - SUBMISSION BASED ON PHASE 2/3 STUDY OF MRNA-1273 IN ADOLESCENTS AGES 12 TO LESS THAN 18 IN U.S..

Saudi's AIG Unit Signs Contract To Commercialize Moderna’s COVID-19 Vaccine in Saudi

June 13 (Reuters) - ASTRA INDUSTRIAL GROUP <1212.SE>::TABUK PHARMACEUTICAL HAS SIGNED A CONTRACT WITH MODERNA.CONTRACT WITH MODERNA TO COMMERCIALIZE MODERNA’S COVID-19 VACCINE AND ITS VARIANTS IN SAUDI ARABIA.EXCLUSIVE SERVICE AGREEMENT WAS SIGNED WITH MODERNA SWITZERLAND GMBH TO SELL AND DISTRIBUTE THEIR mRNA COVID 19 VACCINES AND ITS VARIANTS DEVELOPED BY MODERNA FOR PUBLIC AND PRIVATE SECTORS IN KSA.IN ADDITION, THE AGREEMENT SCOPE INCLUDES OBTAINING AND MAINTAINING ANY REQUIRED AUTHORIZATION INCLUDING REGISTRATION OF PRODUCTS WITH SFDA AND CARRYING OUT PHARMACOVIGILANCE ACTIVITIES.CONTRACT DURATION 3 YEARS RENEWABLE UPON BOTH PARTIES CONSENT.

Moderna Inc Announced Intention To Expand Its Manufacturing Capabilities

June 9 (Reuters) - Moderna Inc <MRNA.O>::MODERNA INC - ANNOUNCED INTENTION TO EXPAND ITS MANUFACTURING CAPABILITIES TO POTENTIALLY SUPPLY UP TO 3 BILLION DOSES OF ITS COVID-19 VACCINE IN 2022..MODERNA - INTERESTED IN POSSIBILITY OF PARTNERING WITH U.S. TO PROVIDE ADDITIONAL DOSES OF CO’S COVID-19 VACCINE IN LOW- AND MIDDLE-INCOME COUNTRIES.MODERNA INC - CO WOULD NOT BE PROVIDING ADDITIONAL DETAILS ABOUT ANY PARTICULAR DISCUSSIONS.

Valo Health To Go Public Through SPAC Deal- WSJ

June 9 (Reuters) - :VALO HEALTH TO GO PUBLIC THROUGH SPAC DEAL- WSJ.VALO HEALTH IS GOING PUBLIC THROUGH COMBINATION WITH A SPAC, A DEAL THAT VALUES THE COMBINED ENTITY AT ABOUT $2.8 BILLION- WSJ. ((Reuters.Briefs@thomsonreuters.com;)).

EMA Says Outcome On Moderna COVID-19 Shot Use In Teenagers Expected In July

June 8 (Reuters) - European Medicines Agency (EMA):EMA EVALUATING THE USE OF COVID-19 VACCINE MODERNA IN YOUNG PEOPLE AGED 12 TO 17.SAYS WILL COMMUNICATE THE OUTCOME OF MODERNA VACCINE EXTENSION EVALUATION, WHICH IS EXPECTED IN JULY UNLESS SUPPLEMENTARY INFORMATION IS NEEDED.SAYS COVID-19 VACCINE MODERNA IS CURRENTLY AUTHORISED FOR USE IN PEOPLE AGED 18 AND OLDER.Further company coverage: MRNA.O. ((Reuters.Briefs@thomsonreuters.com;)).

Moderna Files For Authorization With Health Canada For Its Covid-19 Vaccine In Adolescents

June 7 (Reuters) - Moderna Inc <MRNA.O>::MODERNA FILES FOR AUTHORIZATION WITH HEALTH CANADA FOR ITS COVID-19 VACCINE IN ADOLESCENTS.MODERNA INC - SUBMISSION WITH HEALTH CANADA BASED ON PHASE 2/3 STUDY OF MRNA-1273 IN ADOLESCENTS AGES 12 TO LESS THAN 18 IN U.S..

Unicef And Moderna Announce Long Term Agreement To Supply Vaccine On Behalf Of Covax Facility

June 2 (Reuters) - Moderna Inc <MRNA.O>::UNICEF AND MODERNA ANNOUNCE LONG TERM AGREEMENT TO SUPPLY VACCINE ON BEHALF OF COVAX FACILITY.MODERNA INC - AGREEMENT TO SUPPLY 34 MILLION DOSES OF COVID-19 VACCINE MODERNA IN Q4 OF 2021.MODERNA INC - OPTION TO SUPPLY UP TO 466 MILLION DOSES IN 2022.MODERNA INC - ALL DOSES ARE OFFERED AT MODERNA'S LOWEST TIERED PRICE.

Moderna Announces Deal With Thermo Fisher Scientific For Fill/Finish Manufacturing Of COVID-19 Vaccine

June 1 (Reuters) - Moderna Inc <MRNA.O>::MODERNA ANNOUNCES AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR FILL/FINISH MANUFACTURING OF MODERNA’S COVID-19 VACCINE.MODERNA INC - PRODUCTION WILL BEGIN IN Q3 OF 2021..MODERNA INC - THERMO FISHER'S COMMERCIAL MANUFACTURING SITE IN GREENVILLE, NORTH CAROLINA WILL BE USED FOR ASEPTIC FILL/FINISH, LABELING AND PACKAGING.MODERNA INC - DEAL TO SUPPORT PRODUCTION OF HUNDREDS OF MILLIONS OF DOSES OF MODERNA COVID-19 VACCINE.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up